FTC Sues to Block Merger of Rivals Developing Treatment for Faulty Aortic Valves
A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing Edwards Lifesciences to buy JenaValve would reduce that number to one.
CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.
Click Here To Read The Full Article
Navigation 